• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » WCCT Global launches Orphan Drug program, In-Site patient recruitment

WCCT Global launches Orphan Drug program, In-Site patient recruitment

February 19, 2014
CenterWatch Staff

WCCT Global, a Southern California-based CRO, has announced a specialized program to conduct clinical research for sponsors engaged in Orphan Drug development.  

Aside from the often referenced technical and commercial hurdles which must be overcome before launching a development program for an orphan indication, the necessity to attain adequate patient recruitment for safety and efficacy trials in support of the intended orphan indication offers an equal or greater challenge. 

WCCT Global's proprietary In-Site patient recruitment method, which utilizes multiple levels of advanced digital technologies designed to work, in concert, to facilitate successful patient recruitment, focuses on identification of desired patients based on the utilization of multiple proprietary patient databases.

WCCT Global can not only locate patient groups, but determine the best sites to conduct clinical trial, making orphan disease recruitment more efficient for the investigative site and, ultimately, for the sponsor.

In-Site is an advanced digital advertising process by which WCCT Global can create an in-depth psychographic based on the orphan indication and apply specific targeting methods across digital and social media outlets to ensure ideally targeted patient access.

Jon Rojas, WCCT Global's chief operating officer, said, "Our In-Site proprietary recruitment tool can play a vital role leading to the successful recruitment of clinical trials in support of Orphan Drug development programs."

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing